1. Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites.
- Author
-
Teng, Yun, Luo, Chao, Qiu, Xiaolan, Mu, Jingyao, Sriwastva, Mukesh K., Xu, Qingbo, Liu, Minmin, Hu, Xin, Xu, Fangyi, Zhang, Lifeng, Park, Juw Won, Hwang, Jae Yeon, Kong, Maiying, Liu, Zhanxu, Zhang, Xiang, Xu, Raobo, Yan, Jun, Merchant, Michael L., McClain, Craig J., and Zhang, Huang-Ge
- Subjects
PHOSPHOLIPASE C ,DOCOSAHEXAENOIC acid ,GUT microbiome ,HUMAN microbiota ,GENETIC transcription - Abstract
Diet has emerged as a key impact factor for gut microbiota function. However, the complexity of dietary components makes it difficult to predict specific outcomes. Here we investigate the impact of plant-derived nanoparticles (PNP) on gut microbiota and metabolites in context of cancer immunotherapy with the humanized gnotobiotic mouse model. Specifically, we show that ginger-derived exosome-like nanoparticle (GELN) preferentially taken up by Lachnospiraceae and Lactobacillaceae mediated by digalactosyldiacylglycerol (DGDG) and glycine, respectively. We further demonstrate that GELN aly-miR159a-3p enhances anti-PD-L1 therapy in melanoma by inhibiting the expression of recipient bacterial phospholipase C (PLC) and increases the accumulation of docosahexaenoic acid (DHA). An increased level of circulating DHA inhibits PD-L1 expression in tumor cells by binding the PD-L1 promoter and subsequently prevents c-myc-initiated transcription of PD-L1. Colonization of germ-free male mice with gut bacteria from anti-PD-L1 non-responding patients supplemented with DHA enhances the efficacy of anti-PD-L1 therapy compared to controls. Our findings reveal a previously unknown mechanistic impact of PNP on human tumor immunotherapy by modulating gut bacterial metabolic pathways. The impact of diet on gut microbiota and metabolites in context of cancer immunotherapy remains elusive. Here the authors reveal ginger-derived exosome-like nanoparticle (GELN) aly-miR159a-3p enhances anti-PD-L1 therapy by increasing microbiota-dependent docosahexaenoic acid (DHA) level thus limiting tumor cell PD-L1 expression. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF